Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axsome Therapeutics, Inc. | 23,710 | reported | 22 Apr 2026 | tx 11+61,905−30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Apr 2026 | GRANT_AWARD | Axsome Therapeutics, Inc. | 7,224 | 0.00 USD | deriv |
| 22 Apr 2026 | EXERCISE | Axsome Therapeutics, Inc. | 7,500 | 70.73 USD | 10b5-1 |
| 22 Apr 2026 | SALE | Axsome Therapeutics, Inc. | 7,500 | 182.42 USD | 10b5-1 |
| 22 Apr 2026 | EXERCISE | Axsome Therapeutics, Inc. | 7,500 | 0.00 USD | 10b5-1deriv |
| 26 Feb 2026 | GRANT_AWARD | Axsome Therapeutics, Inc. | 16,385 | 0.00 USD | deriv |
| 21 Jan 2026 | SALE | Axsome Therapeutics, Inc. | 7,500 | 184.44 USD | |
| 21 Jan 2026 | EXERCISE | Axsome Therapeutics, Inc. | 7,500 | 70.73 USD | |
| 21 Jan 2026 | EXERCISE | Axsome Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 21 Feb 2025 | GRANT_AWARD | Axsome Therapeutics, Inc. | 7,740 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | Axsome Therapeutics, Inc. | 7,740 | 0.00 USD | deriv |
| 21 Feb 2025 | GRANT_AWARD | Axsome Therapeutics, Inc. | 7,816 | 0.00 USD | deriv |